Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Oct 1;100(7):1716–1724. doi: 10.1172/JCI119696

1,25-Dihydroxyvitamin D3 and its analogues inhibit acute myelogenous leukemia progenitor proliferation by suppressing interleukin-1beta production.

S Peleg 1, H Qiu 1, S Reddy 1, D Harris 1, Q Van 1, E H Estey 1, M Talpaz 1, Z Estrov 1
PMCID: PMC508354  PMID: 9312169

Abstract

We hypothesized that 1,25-dihydroxyvitamin D3 (1,25D3) and its analogues may inhibit acute myelogenous leukemia (AML) proliferation by interrupting IL-1beta-mediated growth-stimulatory signals. The incubation of the IL-1beta- responsive AML cell line OCIM2 with 10 nM 1,25D3 reduced growth 80% in liquid culture, and a 100-1000-fold lower concentration of 20-epi analogues (MC1288 and MC1301) was sufficient to achieve similar growth inhibition. The growth inhibition was associated with a rapid but transient downregulation of IL-1beta and IL-1beta-converting enzyme (ICE) mRNAs in 1,25D3- and 20-epi analogue- treated cells, and the 20-epi analogue was more effective than 1,25D3 in repressing ICE expression. An examination of long-term changes in the levels of mature IL-1beta and its precursor revealed that 24-h incubation of OCIM2 with either 1,25D3 or its 20-epi analogues abolished the production of mature IL-1beta. The effect of 1,25D3 and its analogues on growth of fresh bone marrow cells from seven AML patients was tested by a clonogenic assay. Growth inhibition of 60% was reached in only one of seven 1,25D3-treated samples, but all seven samples were inhibited 60-90% by the 20-epi analogue MC1301. Growth inhibition by 1,25D3 and the analogue was reversible by addition of IL-1beta. These results suggest that 1,25D3 and its 20-epi analogues interrupt IL-1beta autocrine growth regulation by inhibiting IL-1beta production and processing but not the response to IL-1beta.

Full Text

The Full Text of this article is available as a PDF (297.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe E., Miyaura C., Sakagami H., Takeda M., Konno K., Yamazaki T., Yoshiki S., Suda T. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1981 Aug;78(8):4990–4994. doi: 10.1073/pnas.78.8.4990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bar-Shavit Z., Kahn A. J., Stone K. R., Trial J., Hilliard T., Reitsma P. H., Teitelbaum S. L. Reversibility of vitamin D-induced human leukemia cell-line maturation. Endocrinology. 1986 Feb;118(2):679–686. doi: 10.1210/endo-118-2-679. [DOI] [PubMed] [Google Scholar]
  3. Bar-Shavit Z., Teitelbaum S. L., Reitsma P., Hall A., Pegg L. E., Trial J., Kahn A. J. Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1983 Oct;80(19):5907–5911. doi: 10.1073/pnas.80.19.5907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bertoncello I., Bradley T. R., Watt S. M. An improved negative immunomagnetic selection strategy for the purification of primitive hemopoietic cells from normal bone marrow. Exp Hematol. 1991 Feb;19(2):95–100. [PubMed] [Google Scholar]
  5. Black R. A., Kronheim S. R., Cantrell M., Deeley M. C., March C. J., Prickett K. S., Wignall J., Conlon P. J., Cosman D., Hopp T. P. Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem. 1988 Jul 5;263(19):9437–9442. [PubMed] [Google Scholar]
  6. Boise L. H., Gorse K. M., Westin E. H. Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation. Oncogene. 1992 Sep;7(9):1817–1825. [PubMed] [Google Scholar]
  7. Bouillon R., Okamura W. H., Norman A. W. Structure-function relationships in the vitamin D endocrine system. Endocr Rev. 1995 Apr;16(2):200–257. doi: 10.1210/edrv-16-2-200. [DOI] [PubMed] [Google Scholar]
  8. Bradbury D., Rogers S., Reilly I. A., Kozlowski R., Russell N. H. Role of autocrine and paracrine production of granulocyte-macrophage colony-stimulating factor and interleukin-1 beta in the autonomous growth of acute myeloblastic leukaemia cells--studies using purified CD34-positive cells. Leukemia. 1992 Jun;6(6):562–566. [PubMed] [Google Scholar]
  9. Buick R. N., Till J. E., McCulloch E. A. Colony assay for proliferative blast cells circulating in myeloblastic leukaemia. Lancet. 1977 Apr 16;1(8016):862–863. doi: 10.1016/s0140-6736(77)92818-5. [DOI] [PubMed] [Google Scholar]
  10. Cerretti D. P., Kozlosky C. J., Mosley B., Nelson N., Van Ness K., Greenstreet T. A., March C. J., Kronheim S. R., Druck T., Cannizzaro L. A. Molecular cloning of the interleukin-1 beta converting enzyme. Science. 1992 Apr 3;256(5053):97–100. doi: 10.1126/science.1373520. [DOI] [PubMed] [Google Scholar]
  11. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  12. Cozzolino F., Rubartelli A., Aldinucci D., Sitia R., Torcia M., Shaw A., Di Guglielmo R. Interleukin 1 as an autocrine growth factor for acute myeloid leukemia cells. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2369–2373. doi: 10.1073/pnas.86.7.2369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dinarello C. A. Biologic basis for interleukin-1 in disease. Blood. 1996 Mar 15;87(6):2095–2147. [PubMed] [Google Scholar]
  14. Dinarello C. A. Interleukin-1 and interleukin-1 antagonism. Blood. 1991 Apr 15;77(8):1627–1652. [PubMed] [Google Scholar]
  15. Estrov Z., Black R. A., Sleath P. R., Harris D., Van Q., LaPushin R., Estey E. H., Talpaz M. Effect of interleukin-1 beta converting enzyme inhibitor on acute myelogenous leukemia progenitor proliferation. Blood. 1995 Dec 15;86(12):4594–4602. [PubMed] [Google Scholar]
  16. Estrov Z., Cohen A., Gelfand E. W., Freedman M. H. Synergistic antiproliferative effects on HL-60 cells: deferoxamine enhances cytosine arabinoside, methotrexate, and daunorubicin cytotoxicity. Am J Pediatr Hematol Oncol. 1988 Winter;10(4):288–291. doi: 10.1097/00043426-198824000-00003. [DOI] [PubMed] [Google Scholar]
  17. Estrov Z., Grunberger T., Chan H. S., Freedman M. H. Juvenile chronic myelogenous leukemia: characterization of the disease using cell cultures. Blood. 1986 May;67(5):1382–1387. [PubMed] [Google Scholar]
  18. Estrov Z., Kurzrock R., Estey E., Wetzler M., Ferrajoli A., Harris D., Blake M., Gutterman J. U., Talpaz M. Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors. Blood. 1992 Apr 15;79(8):1938–1945. [PubMed] [Google Scholar]
  19. Freedman M. H., Chan H. S., Chang L. Childhood erythroleukemia. Studies on pathogenesis using colony assays. Am J Pediatr Hematol Oncol. 1986 Spring;8(1):2–7. [PubMed] [Google Scholar]
  20. Gershoni J. M., Palade G. E. Protein blotting: principles and applications. Anal Biochem. 1983 May;131(1):1–15. doi: 10.1016/0003-2697(83)90128-8. [DOI] [PubMed] [Google Scholar]
  21. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982 Sep;2(9):1044–1051. doi: 10.1128/mcb.2.9.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hoang T., Haman A., Goncalves O., Wong G. G., Clark S. C. Interleukin-6 enhances growth factor-dependent proliferation of the blast cells of acute myeloblastic leukemia. Blood. 1988 Aug;72(2):823–826. [PubMed] [Google Scholar]
  23. Komiyama T., Ray C. A., Pickup D. J., Howard A. D., Thornberry N. A., Peterson E. P., Salvesen G. Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. J Biol Chem. 1994 Jul 29;269(30):19331–19337. [PubMed] [Google Scholar]
  24. Kostura M. J., Tocci M. J., Limjuco G., Chin J., Cameron P., Hillman A. G., Chartrain N. A., Schmidt J. A. Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci U S A. 1989 Jul;86(14):5227–5231. doi: 10.1073/pnas.86.14.5227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Liu M., Lee M. H., Cohen M., Bommakanti M., Freedman L. P. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 1996 Jan 15;10(2):142–153. doi: 10.1101/gad.10.2.142. [DOI] [PubMed] [Google Scholar]
  26. Liu Y. Y., Collins E. D., Norman A. W., Peleg S. Differential interaction of 1alpha,25-dihydroxyvitamin D3 analogues and their 20-epi homologues with the vitamin D receptor. J Biol Chem. 1997 Feb 7;272(6):3336–3345. doi: 10.1074/jbc.272.6.3336. [DOI] [PubMed] [Google Scholar]
  27. Mangelsdorf D. J., Koeffler H. P., Donaldson C. A., Pike J. W., Haussler M. R. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol. 1984 Feb;98(2):391–398. doi: 10.1083/jcb.98.2.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Miller D. K., Calaycay J. R., Chapman K. T., Howard A. D., Kostura M. J., Molineaux S. M., Thornberry N. A. The IL-1 beta converting enzyme as a therapeutic target. Ann N Y Acad Sci. 1993 Nov 30;696:133–148. doi: 10.1111/j.1749-6632.1993.tb17148.x. [DOI] [PubMed] [Google Scholar]
  29. Minden M. D., Buick R. N., McCulloch E. A. Separation of blast cell and T-lymphocyte progenitors in the blood of patients with acute myeloblastic leukemia. Blood. 1979 Jul;54(1):186–195. [PubMed] [Google Scholar]
  30. Miossec C., Decoen M. C., Durand L., Fassy F., Diu-Hercend A. Use of monoclonal antibodies to study interleukin-1 beta-converting enzyme expression: only precursor forms are detected in interleukin-1 beta-secreting cells. Eur J Immunol. 1996 May;26(5):1032–1042. doi: 10.1002/eji.1830260512. [DOI] [PubMed] [Google Scholar]
  31. Miyauchi J., Kelleher C. A., Wong G. G., Yang Y. C., Clark S. C., Minkin S., Minden M. D., McCulloch E. A. The effects of combinations of the recombinant growth factors GM-CSF, G-CSF, IL-3, and CSF-1 on leukemic blast cells in suspension culture. Leukemia. 1988 Jun;2(6):382–387. [PubMed] [Google Scholar]
  32. Nett M. A., Cerretti D. P., Berson D. R., Seavitt J., Gilbert D. J., Jenkins N. A., Copeland N. G., Black R. A., Chaplin D. D. Molecular cloning of the murine IL-1 beta converting enzyme cDNA. J Immunol. 1992 Nov 15;149(10):3254–3259. [PubMed] [Google Scholar]
  33. Papayannopoulou T., Nakamoto B., Kurachi S., Tweeddale M., Messner H. Surface antigenic profile and globin phenotype of two new human erythroleukemia lines: characterization and interpretations. Blood. 1988 Sep;72(3):1029–1038. [PubMed] [Google Scholar]
  34. Peleg S., Abruzzese R. V., Cote G. J., Gagel R. F. Transcription of the human calcitonin gene is mediated by a C cell-specific enhancer containing E-box-like elements. Mol Endocrinol. 1990 Nov;4(11):1750–1757. doi: 10.1210/mend-4-11-1750. [DOI] [PubMed] [Google Scholar]
  35. Peleg S., Liu Y. Y., Reddy S., Horst R. L., White M. C., Posner G. H. A 20-epi side chain restores growth-regulatory and transcriptional activities of an A ring-modified hybrid analog of 1 alpha, 25-dihydroxyvitamin D3 without increasing its affinity to the vitamin D receptor. J Cell Biochem. 1996 Nov 1;63(2):149–161. doi: 10.1002/(sici)1097-4644(19961101)63:2<149::aid-jcb3>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  36. Rambaldi A., Torcia M., Bettoni S., Vannier E., Barbui T., Shaw A. R., Dinarello C. A., Cozzolino F. Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells. Blood. 1991 Dec 15;78(12):3248–3253. [PubMed] [Google Scholar]
  37. Reitsma P. H., Rothberg P. G., Astrin S. M., Trial J., Bar-Shavit Z., Hall A., Teitelbaum S. L., Kahn A. J. Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature. 1983 Dec 1;306(5942):492–494. doi: 10.1038/306492a0. [DOI] [PubMed] [Google Scholar]
  38. Rodriguez-Cimadevilla J. C., Beauchemin V., Villeneuve L., Letendre F., Shaw A., Hoang T. Coordinate secretion of interleukin-1 beta and granulocyte-macrophage colony-stimulating factor by the blast cells of acute myeloblastic leukemia: role of interleukin-1 as an endogenous inducer. Blood. 1990 Oct 15;76(8):1481–1489. [PubMed] [Google Scholar]
  39. Segal G. M., McCall E., Stueve T., Bagby G. C., Jr Interleukin 1 stimulates endothelial cells to release multilineage human colony-stimulating activity. J Immunol. 1987 Mar 15;138(6):1772–1778. [PubMed] [Google Scholar]
  40. Shaw G. M., Levy P. C., LoBuglio A. F. Human monocyte antibody-dependent cell-mediated cytotoxicity to tumor cells. J Clin Invest. 1978 Dec;62(6):1172–1180. doi: 10.1172/JCI109236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Sone T., Kerner S., Pike J. W. Vitamin D receptor interaction with specific DNA. Association as a 1,25-dihydroxyvitamin D3-modulated heterodimer. J Biol Chem. 1991 Dec 5;266(34):23296–23305. [PubMed] [Google Scholar]
  42. Souza L. M., Boone T. C., Gabrilove J., Lai P. H., Zsebo K. M., Murdock D. C., Chazin V. R., Bruszewski J., Lu H., Chen K. K. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science. 1986 Apr 4;232(4746):61–65. doi: 10.1126/science.2420009. [DOI] [PubMed] [Google Scholar]
  43. Studzinski G. P., McLane J. A., Uskoković M. R. Signaling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases. Crit Rev Eukaryot Gene Expr. 1993;3(4):279–312. [PubMed] [Google Scholar]
  44. Thornberry N. A., Bull H. G., Calaycay J. R., Chapman K. T., Howard A. D., Kostura M. J., Miller D. K., Molineaux S. M., Weidner J. R., Aunins J. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature. 1992 Apr 30;356(6372):768–774. doi: 10.1038/356768a0. [DOI] [PubMed] [Google Scholar]
  45. Walters M. R. Newly identified actions of the vitamin D endocrine system. Endocr Rev. 1992 Nov;13(4):719–764. doi: 10.1210/edrv-13-4-719. [DOI] [PubMed] [Google Scholar]
  46. Wang S., Miura M., Jung Y. k., Zhu H., Gagliardini V., Shi L., Greenberg A. H., Yuan J. Identification and characterization of Ich-3, a member of the interleukin-1beta converting enzyme (ICE)/Ced-3 family and an upstream regulator of ICE. J Biol Chem. 1996 Aug 23;271(34):20580–20587. doi: 10.1074/jbc.271.34.20580. [DOI] [PubMed] [Google Scholar]
  47. Yin M., Gopal V., Banavali S., Gartside P., Preisler H. Effects of an IL-1 receptor antagonist on acute myeloid leukemia cells. Leukemia. 1992 Sep;6(9):898–901. [PubMed] [Google Scholar]
  48. Young D. C., Griffin J. D. Autocrine secretion of GM-CSF in acute myeloblastic leukemia. Blood. 1986 Nov;68(5):1178–1181. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES